Literature DB >> 32295799

Diagnostic and management considerations in the modern patient with AIDS: a case of concurrent disseminated Kaposi sarcoma and colesional Cryptococcus neoformans.

Samuel Clay Williams1, Jacob Sweeney2, Lalitha Parameswaran3.   

Abstract

In the era of highly active antiretroviral therapy (HAART), disseminated Kaposi sarcoma (KS) has become much rarer in the USA. We report a case of a 34-year-old man with KS of the skin, oropharynx, lung and rectum. Within the same lung nodule, we discovered significant burden of colesional Cryptococcus neoformans, in the context of a positive asymptomatic cryptococcal antigenemia, which was a previously unreported occurrence. The gold standard of treatment for KS continues to be HAART. The role of chemotherapy is still controversial. In addition, a cryptococcal antigen screen-and-treat approach with fluconazole is still not routinely recommended in the USA to prevent serious meningeal disease despite recent studies showing efficacy and applicability. We discuss both issues here and the outcome of our patient. We also present the patient's own unique perspective in dealing with the ramifications of these diagnoses. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Cryptococcus; HIV / AIDS; drugs: infectious diseases; infectious diseases; skin cancer

Mesh:

Substances:

Year:  2020        PMID: 32295799      PMCID: PMC7199148          DOI: 10.1136/bcr-2019-233860

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  Simultaneous occurrence of Kaposi's sarcoma and Cryptococcus within a cutaneous lesion in a patient with acquired immunodeficiency syndrome.

Authors:  M S Sofman; E R Heilman
Journal:  Arch Dermatol       Date:  1990-05

Review 2.  Cryptococcosis.

Authors:  Eileen K Maziarz; John R Perfect
Journal:  Infect Dis Clin North Am       Date:  2016-03       Impact factor: 5.982

3.  Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012.

Authors:  Jennie McKenney; Sean Bauman; Brandon Neary; Roger Detels; Audrey French; Joseph Margolick; Brian Doherty; Jeffrey D Klausner
Journal:  Clin Infect Dis       Date:  2014-11-24       Impact factor: 9.079

Review 4.  Coexistent Kaposi sarcoma, cryptococcosis, and Mycobacterium avium intracellulare in a solitary cutaneous nodule in a patient with AIDS: report of a case and literature review.

Authors:  Thomas A Pietras; Christian L Baum; Brian L Swick
Journal:  J Am Acad Dermatol       Date:  2010-04       Impact factor: 11.527

Review 5.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 6.  Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.

Authors:  Oluwatoyin F Gbabe; Charles I Okwundu; Martin Dedicoat; Esther E Freeman
Journal:  Cochrane Database Syst Rev       Date:  2014-08-13

7.  Prospective stage-stratified approach to AIDS-related Kaposi's sarcoma.

Authors:  Mark Bower; Alessia Dalla Pria; Chris Coyle; Eileen Andrews; Victoria Tittle; Sharanjit Dhoot; Mark Nelson
Journal:  J Clin Oncol       Date:  2013-12-30       Impact factor: 44.544

8.  Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection.

Authors:  Hitomi Fukumoto; Takayuki Kanno; Hideki Hasegawa; Harutaka Katano
Journal:  Front Microbiol       Date:  2011-08-25       Impact factor: 5.640

9.  Severe clinical immunodeficiency in a patient with human immunodeficiency virus infection and relatively high CD4 counts: a case report.

Authors:  Mickael Essouma; Larry N Tangie; Mazou N Temgoua; Ulrich Gabin Kenfack; Antonin N Ndam; Celestin Danwang
Journal:  J Med Case Rep       Date:  2019-03-14

10.  Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.

Authors:  Joseph N Jarvis; Thomas S Harrison; Stephen D Lawn; Graeme Meintjes; Robin Wood; Susan Cleary
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.